Europe Botulinum Neurotoxins Market Report 2016

Publisher Name :
Date: 09-Oct-2016
No. of pages: 121
Inquire Before Buying

Notes:

Sales, means the sales volume of Botulinum Neurotoxins

Revenue, means the sales value of Botulinum Neurotoxins

This report studies sales (consumption) of Botulinum Neurotoxins in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

- Johnson & Johnson

- GSK

- Allergan

- Chong Kun Dang

- Eisai

- Nestle

- Galderma

- Ipsen

- Hugel

- Mentor

- CROMA

- Alphaeon

- OBI Pharma

- Revance Therapeutics

- Daewoong Pharmaceutical

- Medy-Tox

- EpiVax

- Anterios

- Escape Therapeutics

- Lipella

- Malvern Cosmeceutics

- PharmaVital

- Merz Pharma

- Transdermal

- Valeant Pharmaceuticals

- CNBG

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Botulinum Neurotoxins in these countries, from 2011 to 2021 (forecast), like

- Germany

- France

- UK

- Russia

- Italy

- Spain

- Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Botulinum Neurotoxins A (BoNT/A)

- Botulinum Neurotoxins B (BoNT/B)

- Botulinum Neurotoxins E (BoNT/E)

- Botulinum Neurotoxins F (BoNT/F)

- Botulinum Neurotoxins C (BoNT/C)

- Botulinum Neurotoxins D (BoNT/D)

- Botulinum Neurotoxins G (BoNT/G)

Split by application, this report focuses on sales, market share and growth rate of Botulinum Neurotoxins in each application, can be divided into

- Medical Uses

- Cosmetics

- Application 3

Europe Botulinum Neurotoxins Market Report 2016

Table of Contents
Europe Botulinum Neurotoxins Market Report 2016
1 Botulinum Neurotoxins Overview
1.1 Product Overview and Scope of Botulinum Neurotoxins
1.2 Classification of Botulinum Neurotoxins
1.2.1 Botulinum Neurotoxins A (BoNT/A)
1.2.2 Botulinum Neurotoxins B (BoNT/B)
1.2.3 Botulinum Neurotoxins E (BoNT/E)
1.2.4 Botulinum Neurotoxins F (BoNT/F)
1.2.5 Botulinum Neurotoxins C (BoNT/C)
1.2.6 Botulinum Neurotoxins D (BoNT/D)
1.2.7 Botulinum Neurotoxins G (BoNT/G)
1.3 Application of Botulinum Neurotoxins
1.3.1 Medical Uses
1.3.2 Cosmetics
1.3.3 Application 3
1.4 Botulinum Neurotoxins Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Botulinum Neurotoxins (2011-2021)
1.5.1 Europe Botulinum Neurotoxins Sales and Growth Rate (2011-2021)
1.5.2 Europe Botulinum Neurotoxins Revenue and Growth Rate (2011-2021)
2 Europe Botulinum Neurotoxins by Manufacturers, Type and Application
2.1 Europe Botulinum Neurotoxins Market Competition by Manufacturers
2.1.1 Europe Botulinum Neurotoxins Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Botulinum Neurotoxins Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Botulinum Neurotoxins (Volume and Value) by Type
2.2.1 Europe Botulinum Neurotoxins Sales and Market Share by Type (2011-2016)
2.2.2 Europe Botulinum Neurotoxins Revenue and Market Share by Type (2011-2016)
2.3 Europe Botulinum Neurotoxins (Volume and Value) by Countries
2.3.1 Europe Botulinum Neurotoxins Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Botulinum Neurotoxins Revenue and Market Share by Countries (2011-2016)
2.4 Europe Botulinum Neurotoxins (Volume) by Application
3 Germany Botulinum Neurotoxins (Volume, Value and Sales Price)
3.1 Germany Botulinum Neurotoxins Sales and Value (2011-2016)
3.1.1 Germany Botulinum Neurotoxins Sales and Growth Rate (2011-2016)
3.1.2 Germany Botulinum Neurotoxins Revenue and Growth Rate (2011-2016)
3.1.3 Germany Botulinum Neurotoxins Sales Price Trend (2011-2016)
3.2 Germany Botulinum Neurotoxins Sales and Market Share by Manufacturers
3.3 Germany Botulinum Neurotoxins Sales and Market Share by Type
3.4 Germany Botulinum Neurotoxins Sales and Market Share by Application
4 France Botulinum Neurotoxins (Volume, Value and Sales Price)
4.1 France Botulinum Neurotoxins Sales and Value (2011-2016)
4.1.1 France Botulinum Neurotoxins Sales and Growth Rate (2011-2016)
4.1.2 France Botulinum Neurotoxins Revenue and Growth Rate (2011-2016)
4.1.4 France Botulinum Neurotoxins Sales Price Trend (2011-2016)
4.2 France Botulinum Neurotoxins Sales and Market Share by Manufacturers
4.3 France Botulinum Neurotoxins Sales and Market Share by Type
4.4 France Botulinum Neurotoxins Sales and Market Share by Application
5 UK Botulinum Neurotoxins (Volume, Value and Sales Price)
5.1 UK Botulinum Neurotoxins Sales and Value (2011-2016)
5.1.1 UK Botulinum Neurotoxins Sales and Growth Rate (2011-2016)
5.1.2 UK Botulinum Neurotoxins Revenue and Growth Rate (2011-2016)
5.1.5 UK Botulinum Neurotoxins Sales Price Trend (2011-2016)
5.2 UK Botulinum Neurotoxins Sales and Market Share by Manufacturers
5.3 UK Botulinum Neurotoxins Sales and Market Share by Type
5.4 UK Botulinum Neurotoxins Sales and Market Share by Application
6 Russia Botulinum Neurotoxins (Volume, Value and Sales Price)
6.1 Russia Botulinum Neurotoxins Sales and Value (2011-2016)
6.1.1 Russia Botulinum Neurotoxins Sales and Growth Rate (2011-2016)
6.1.2 Russia Botulinum Neurotoxins Revenue and Growth Rate (2011-2016)
6.1.6 Russia Botulinum Neurotoxins Sales Price Trend (2011-2016)
6.2 Russia Botulinum Neurotoxins Sales and Market Share by Manufacturers
6.3 Russia Botulinum Neurotoxins Sales and Market Share by Type
6.4 Russia Botulinum Neurotoxins Sales and Market Share by Application
7 Italy Botulinum Neurotoxins (Volume, Value and Sales Price)
7.1 Italy Botulinum Neurotoxins Sales and Value (2011-2016)
7.1.1 Italy Botulinum Neurotoxins Sales and Growth Rate (2011-2016)
7.1.2 Italy Botulinum Neurotoxins Revenue and Growth Rate (2011-2016)
7.1.7 Italy Botulinum Neurotoxins Sales Price Trend (2011-2016)
7.2 Italy Botulinum Neurotoxins Sales and Market Share by Manufacturers
7.3 Italy Botulinum Neurotoxins Sales and Market Share by Type
7.4 Italy Botulinum Neurotoxins Sales and Market Share by Application
8 Spain Botulinum Neurotoxins (Volume, Value and Sales Price)
8.1 Spain Botulinum Neurotoxins Sales and Value (2011-2016)
8.1.1 Spain Botulinum Neurotoxins Sales and Growth Rate (2011-2016)
8.1.2 Spain Botulinum Neurotoxins Revenue and Growth Rate (2011-2016)
8.1.8 Spain Botulinum Neurotoxins Sales Price Trend (2011-2016)
8.2 Spain Botulinum Neurotoxins Sales and Market Share by Manufacturers
8.3 Spain Botulinum Neurotoxins Sales and Market Share by Type
8.4 Spain Botulinum Neurotoxins Sales and Market Share by Application
9 Benelux Botulinum Neurotoxins (Volume, Value and Sales Price)
9.1 Benelux Botulinum Neurotoxins Sales and Value (2011-2016)
9.1.1 Benelux Botulinum Neurotoxins Sales and Growth Rate (2011-2016)
9.1.2 Benelux Botulinum Neurotoxins Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Botulinum Neurotoxins Sales Price Trend (2011-2016)
9.2 Benelux Botulinum Neurotoxins Sales and Market Share by Manufacturers
9.3 Benelux Botulinum Neurotoxins Sales and Market Share by Type
9.4 Benelux Botulinum Neurotoxins Sales and Market Share by Application
10 Europe Botulinum Neurotoxins Manufacturers Analysis
10.1 Johnson & Johnson
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Botulinum Neurotoxins Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Johnson & Johnson Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 GSK
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Botulinum Neurotoxins Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 GSK Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 Allergan
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Botulinum Neurotoxins Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 Allergan Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Chong Kun Dang
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Botulinum Neurotoxins Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 Chong Kun Dang Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 Eisai
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Botulinum Neurotoxins Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 Eisai Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Nestle
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Botulinum Neurotoxins Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 Nestle Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Galderma
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Botulinum Neurotoxins Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Galderma Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 Ipsen
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Botulinum Neurotoxins Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 Ipsen Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 Hugel
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Botulinum Neurotoxins Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 Hugel Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Mentor
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Botulinum Neurotoxins Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 Mentor Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
10.11 CROMA
10.12 Alphaeon
10.13 OBI Pharma
10.14 Revance Therapeutics
10.15 Daewoong Pharmaceutical
10.16 Medy-Tox
10.17 EpiVax
10.18 Anterios
10.19 Escape Therapeutics
10.20 Lipella
10.21 Malvern Cosmeceutics
10.22 PharmaVital
10.23 Merz Pharma
10.24 Transdermal
10.25 Valeant Pharmaceuticals
10.26 CNBG
11 Botulinum Neurotoxins Manufacturing Cost Analysis
11.1 Botulinum Neurotoxins Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Botulinum Neurotoxins
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Botulinum Neurotoxins Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Botulinum Neurotoxins Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Botulinum Neurotoxins Market Forecast (2016-2021)
14.1 Germany Botulinum Neurotoxins Sales Forecast (2016-2021)
14.2 France Botulinum Neurotoxins Sales Forecast (2016-2021)
14.3 UK Botulinum Neurotoxins Sales Forecast (2016-2021)
14.4 Russia Botulinum Neurotoxins Sales Forecast (2016-2021)
14.5 Italy Botulinum Neurotoxins Sales Forecast (2016-2021)
14.6 Spain Botulinum Neurotoxins Sales Forecast (2016-2021)
14.7 Benelux Botulinum Neurotoxins Sales Forecast (2016-2021)
14.8 Europe Botulinum Neurotoxins Sales Forecast by Type (2016-2021)
14.9 Europe Botulinum Neurotoxins Sales Forecast by Application (2016-2021)
15 Research Findings and Conclusion
16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Botulinum Neurotoxins
Table Classification of Botulinum Neurotoxins
Figure Europe Sales Market Share of Botulinum Neurotoxins by Type in 2015
Figure Botulinum Neurotoxins A (BoNT/A) Picture
Figure Botulinum Neurotoxins B (BoNT/B) Picture
Figure Botulinum Neurotoxins E (BoNT/E) Picture
Figure Botulinum Neurotoxins F (BoNT/F) Picture
Figure Botulinum Neurotoxins C (BoNT/C) Picture
Figure Botulinum Neurotoxins D (BoNT/D) Picture
Figure Botulinum Neurotoxins G (BoNT/G) Picture
Table Application of Botulinum Neurotoxins
Figure Europe Sales Market Share of Botulinum Neurotoxins by Application in 2015
Figure Medical Uses Examples
Figure Cosmetics Examples
Figure Germany Botulinum Neurotoxins Revenue and Growth Rate (2011-2021)
Figure France Botulinum Neurotoxins Revenue and Growth Rate (2011-2021)
Figure UK Botulinum Neurotoxins Revenue and Growth Rate (2011-2021)
Figure Russia Botulinum Neurotoxins Revenue and Growth Rate (2011-2021)
Figure Italy Botulinum Neurotoxins Revenue and Growth Rate (2011-2021)
Figure Spain Botulinum Neurotoxins Revenue and Growth Rate (2011-2021)
Figure Benelux Botulinum Neurotoxins Revenue and Growth Rate (2011-2021)
Figure Europe Botulinum Neurotoxins Sales and Growth Rate (2011-2021)
Figure Europe Botulinum Neurotoxins Revenue and Growth Rate (2011-2021)
Table Europe Botulinum Neurotoxins Sales of Key Manufacturers (2015 and 2016)
Table Europe Botulinum Neurotoxins Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Botulinum Neurotoxins Sales Share by Manufacturers
Figure 2016 Botulinum Neurotoxins Sales Share by Manufacturers
Table Europe Botulinum Neurotoxins Revenue by Manufacturers (2015 and 2016)
Table Europe Botulinum Neurotoxins Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Botulinum Neurotoxins Revenue Share by Manufacturers
Table 2016 Europe Botulinum Neurotoxins Revenue Share by Manufacturers
Table Europe Botulinum Neurotoxins Sales and Market Share by Type (2011-2016)
Table Europe Botulinum Neurotoxins Sales Share by Type (2011-2016)
Figure Sales Market Share of Botulinum Neurotoxins by Type (2011-2016)
Figure Europe Botulinum Neurotoxins Sales Growth Rate by Type (2011-2016)
Table Europe Botulinum Neurotoxins Revenue and Market Share by Type (2011-2016)
Table Europe Botulinum Neurotoxins Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Botulinum Neurotoxins by Type (2011-2016)
Figure Europe Botulinum Neurotoxins Revenue Growth Rate by Type (2011-2016)
Table Europe Botulinum Neurotoxins Sales and Market Share by Countries (2011-2016)
Table Europe Botulinum Neurotoxins Sales Share by Countries (2011-2016)
Figure Sales Market Share of Botulinum Neurotoxins by Countries (2011-2016)
Table Europe Botulinum Neurotoxins Revenue and Market Share by Countries (2011-2016)
Table Europe Botulinum Neurotoxins Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Botulinum Neurotoxins by Countries (2011-2016)
Table Europe Botulinum Neurotoxins Sales and Market Share by Application (2011-2016)
Table Europe Botulinum Neurotoxins Sales Share by Application (2011-2016)
Figure Sales Market Share of Botulinum Neurotoxins by Application (2011-2016)
Figure Germany Botulinum Neurotoxins Sales and Growth Rate (2011-2016)
Figure Germany Botulinum Neurotoxins Revenue and Growth Rate (2011-2016)
Figure Germany Botulinum Neurotoxins Sales Price Trend (2011-2016)
Table Germany Botulinum Neurotoxins Sales by Manufacturers (2015 and 2016)
Table Germany Botulinum Neurotoxins Market Share by Manufacturers (2015 and 2016)
Table Germany Botulinum Neurotoxins Sales by Type (2015 and 2016)
Table Germany Botulinum Neurotoxins Market Share by Type (2015 and 2016)
Table Germany Botulinum Neurotoxins Sales by Application (2015 and 2016)
Table Germany Botulinum Neurotoxins Market Share by Application (2015 and 2016)
Figure France Botulinum Neurotoxins Sales and Growth Rate (2011-2016)
Figure France Botulinum Neurotoxins Revenue and Growth Rate (2011-2016)
Figure France Botulinum Neurotoxins Sales Price Trend (2011-2016)
Table France Botulinum Neurotoxins Sales by Manufacturers (2015 and 2016)
Table France Botulinum Neurotoxins Market Share by Manufacturers (2015 and 2016)
Table France Botulinum Neurotoxins Sales by Type (2015 and 2016)
Table France Botulinum Neurotoxins Market Share by Type (2015 and 2016)
Table France Botulinum Neurotoxins Sales by Application (2015 and 2016)
Table France Botulinum Neurotoxins Market Share by Application (2015 and 2016)
Figure UK Botulinum Neurotoxins Sales and Growth Rate (2011-2016)
Figure UK Botulinum Neurotoxins Revenue and Growth Rate (2011-2016)
Figure UK Botulinum Neurotoxins Sales Price Trend (2011-2016)
Table UK Botulinum Neurotoxins Sales by Manufacturers (2015 and 2016)
Table UK Botulinum Neurotoxins Market Share by Manufacturers (2015 and 2016)
Table UK Botulinum Neurotoxins Sales by Type (2015 and 2016)
Table UK Botulinum Neurotoxins Market Share by Type (2015 and 2016)
Table UK Botulinum Neurotoxins Sales by Application (2015 and 2016)
Table UK Botulinum Neurotoxins Market Share by Application (2015 and 2016)
Figure Russia Botulinum Neurotoxins Sales and Growth Rate (2011-2016)
Figure Russia Botulinum Neurotoxins Revenue and Growth Rate (2011-2016)
Figure Russia Botulinum Neurotoxins Sales Price Trend (2011-2016)
Table Russia Botulinum Neurotoxins Sales by Manufacturers (2015 and 2016)
Table Russia Botulinum Neurotoxins Market Share by Manufacturers (2015 and 2016)
Table Russia Botulinum Neurotoxins Sales by Type (2015 and 2016)
Table Russia Botulinum Neurotoxins Market Share by Type (2015 and 2016)
Table Russia Botulinum Neurotoxins Sales by Application (2015 and 2016)
Table Russia Botulinum Neurotoxins Market Share by Application (2015 and 2016)
Figure Italy Botulinum Neurotoxins Sales and Growth Rate (2011-2016)
Figure Italy Botulinum Neurotoxins Revenue and Growth Rate (2011-2016)
Figure Italy Botulinum Neurotoxins Sales Price Trend (2011-2016)
Table Italy Botulinum Neurotoxins Sales by Manufacturers (2015 and 2016)
Table Italy Botulinum Neurotoxins Market Share by Manufacturers (2015 and 2016)
Table Italy Botulinum Neurotoxins Sales by Type (2015 and 2016)
Table Italy Botulinum Neurotoxins Market Share by Type (2015 and 2016)
Table Italy Botulinum Neurotoxins Sales by Application (2015 and 2016)
Table Italy Botulinum Neurotoxins Market Share by Application (2015 and 2016)
Figure Spain Botulinum Neurotoxins Sales and Growth Rate (2011-2016)
Figure Spain Botulinum Neurotoxins Revenue and Growth Rate (2011-2016)
Figure Spain Botulinum Neurotoxins Sales Price Trend (2011-2016)
Table Spain Botulinum Neurotoxins Sales by Manufacturers (2015 and 2016)
Table Spain Botulinum Neurotoxins Market Share by Manufacturers (2015 and 2016)
Table Spain Botulinum Neurotoxins Sales by Type (2015 and 2016)
Table Spain Botulinum Neurotoxins Market Share by Type (2015 and 2016)
Table Spain Botulinum Neurotoxins Sales by Application (2015 and 2016)
Table Spain Botulinum Neurotoxins Market Share by Application (2015 and 2016)
Figure Benelux Botulinum Neurotoxins Sales and Growth Rate (2011-2016)
Figure Benelux Botulinum Neurotoxins Revenue and Growth Rate (2011-2016)
Figure Benelux Botulinum Neurotoxins Sales Price Trend (2011-2016)
Table Benelux Botulinum Neurotoxins Sales by Manufacturers (2015 and 2016)
Table Benelux Botulinum Neurotoxins Market Share by Manufacturers (2015 and 2016)
Table Benelux Botulinum Neurotoxins Sales by Type (2015 and 2016)
Table Benelux Botulinum Neurotoxins Market Share by Type (2015 and 2016)
Table Benelux Botulinum Neurotoxins Sales by Application (2015 and 2016)
Table Benelux Botulinum Neurotoxins Market Share by Application (2015 and 2016)
Table Botulinum Neurotoxins Basic Information List
Table Johnson & Johnson Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Botulinum Neurotoxins Sales Market Share (2011-2016)
Table GSK Basic Information List
Table GSK Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table GSK Botulinum Neurotoxins Sales Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Botulinum Neurotoxins Sales Market Share (2011-2016)
Table Chong Kun Dang Basic Information List
Table Chong Kun Dang Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Chong Kun Dang Botulinum Neurotoxins Sales Market Share (2011-2016)
Table Eisai Basic Information List
Table Eisai Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Botulinum Neurotoxins Sales Market Share (2011-2016)
Table Nestle Basic Information List
Table Nestle Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nestle Botulinum Neurotoxins Sales Market Share (2011-2016)
Table Galderma Basic Information List
Table Galderma Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Galderma Botulinum Neurotoxins Sales Market Share (2011-2016)
Table Ipsen Basic Information List
Table Ipsen Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ipsen Botulinum Neurotoxins Sales Market Share (2011-2016)
Table Hugel Basic Information List
Table Hugel Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hugel Botulinum Neurotoxins Sales Market Share (2011-2016)
Table Mentor Basic Information List
Table Mentor Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mentor Botulinum Neurotoxins Sales Market Share (2011-2016)
Table CROMA Basic Information List
Table CROMA Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table CROMA Botulinum Neurotoxins Sales Market Share (2011-2016)
Table Alphaeon Basic Information List
Table Alphaeon Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alphaeon Botulinum Neurotoxins Sales Market Share (2011-2016)
Table OBI Pharma Basic Information List
Table OBI Pharma Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table OBI Pharma Botulinum Neurotoxins Sales Market Share (2011-2016)
Table Revance Therapeutics Basic Information List
Table Revance Therapeutics Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Revance Therapeutics Botulinum Neurotoxins Sales Market Share (2011-2016)
Table Daewoong Pharmaceutical Basic Information List
Table Daewoong Pharmaceutical Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Daewoong Pharmaceutical Botulinum Neurotoxins Sales Market Share (2011-2016)
Table Medy-Tox Basic Information List
Table Medy-Tox Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medy-Tox Botulinum Neurotoxins Sales Market Share (2011-2016)
Table EpiVax Basic Information List
Table EpiVax Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table EpiVax Botulinum Neurotoxins Sales Market Share (2011-2016)
Table Anterios Basic Information List
Table Anterios Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Anterios Botulinum Neurotoxins Sales Market Share (2011-2016)
Table Escape Therapeutics Basic Information List
Table Escape Therapeutics Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Escape Therapeutics Botulinum Neurotoxins Sales Market Share (2011-2016)
Table Lipella Basic Information List
Table Lipella Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lipella Botulinum Neurotoxins Sales Market Share (2011-2016)
Table Malvern Cosmeceutics Basic Information List
Table Malvern Cosmeceutics Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Malvern Cosmeceutics Botulinum Neurotoxins Sales Market Share (2011-2016)
Table PharmaVital Basic Information List
Table PharmaVital Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table PharmaVital Botulinum Neurotoxins Sales Market Share (2011-2016)
Table Merz Pharma Basic Information List
Table Merz Pharma Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merz Pharma Botulinum Neurotoxins Sales Market Share (2011-2016)
Table Transdermal Basic Information List
Table Transdermal Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Transdermal Botulinum Neurotoxins Sales Market Share (2011-2016)
Table Valeant Pharmaceuticals Basic Information List
Table Valeant Pharmaceuticals Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Valeant Pharmaceuticals Botulinum Neurotoxins Sales Market Share (2011-2016)
Table CNBG Basic Information List
Table CNBG Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)
Table CNBG Botulinum Neurotoxins Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Botulinum Neurotoxins
Figure Manufacturing Process Analysis of Botulinum Neurotoxins
Figure Botulinum Neurotoxins Industrial Chain Analysis
Table Raw Materials Sources of Botulinum Neurotoxins Major Manufacturers in 2015
Table Major Buyers of Botulinum Neurotoxins
Table Distributors/Traders List
Figure Germany Botulinum Neurotoxins Sales and Growth Rate Forecast (2016-2021)
Figure Germany Botulinum Neurotoxins Revenue and Growth Rate Forecast (2016-2021)
Figure France Botulinum Neurotoxins Sales and Growth Rate Forecast (2016-2021)
Figure France Botulinum Neurotoxins Revenue and Growth Rate Forecast (2016-2021)
Figure UK Botulinum Neurotoxins Sales and Growth Rate Forecast (2016-2021)
Figure UK Botulinum Neurotoxins Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Botulinum Neurotoxins Sales and Growth Rate Forecast (2016-2021)
Figure Russia Botulinum Neurotoxins Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Botulinum Neurotoxins Sales and Growth Rate Forecast (2016-2021)
Figure Italy Botulinum Neurotoxins Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Botulinum Neurotoxins Sales and Growth Rate Forecast (2016-2021)
Figure Spain Botulinum Neurotoxins Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Botulinum Neurotoxins Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Botulinum Neurotoxins Revenue and Growth Rate Forecast (2016-2021)
Table Europe Botulinum Neurotoxins Sales Forecast by Type (2016-2021)
Table Europe Botulinum Neurotoxins Sales Forecast by Application (2016-2021)
  • Global Active Pharmaceutical Ingredient Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 05-Dec-2016        Price: US 3480 Onwards        Pages: 112
    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. API also refers to the active or central ingredient in the product which causes the direct effect on the disease diagnosis, prevention, treatment or cure. While API is the active c......
  • Global Epilepsy Drugs Sales Market Report 2016
    Published: 05-Dec-2016        Price: US 4000 Onwards        Pages: 106
    Notes: Sales, means the sales volume of Epilepsy Drugs Revenue, means the sales value of Epilepsy Drugs This report studies sales (consumption) of Epilepsy Drugs in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - GlaxoSmithKline - Pfizer - UCB - Eisai - Roche - Shire......
  • Europe Ganciclovir Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Ganciclovir Revenue, means the sales value of Ganciclovir This report studies sales (consumption) of Ganciclovir in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Roche - Bausch & Lomb - Fresenius Kabi - Luitpold - Huatai Pha......
  • Europe Typhoid Vaccine Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 108
    Notes: Sales, means the sales volume of Typhoid Vaccine Revenue, means the sales value of Typhoid Vaccine This report studies sales (consumption) of Typhoid Vaccine in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Bharat Biotech Int. Ltd. (BBIL) - Bio-Med Pvt. Ltd. - PT BioFarm......
  • Europe Trastuzumab Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 109
    Notes: Sales, means the sales volume of Trastuzumab Revenue, means the sales value of Trastuzumab This report studies sales (consumption) of Trastuzumab in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Bristol-Myers Squibb - Eli Lilly and Company - Merck & Co. - Roche......
  • Europe Thromboxane A2 Receptor Antagonist Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 105
    Notes: Sales, means the sales volume of Thromboxane A2 Receptor Antagonist Revenue, means the sales value of Thromboxane A2 Receptor Antagonist This report studies sales (consumption) of Thromboxane A2 Receptor Antagonist in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Merck & Co. - ......
  • Europe Salagen Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 101
    Notes: Sales, means the sales volume of Salagen Revenue, means the sales value of Salagen This report studies sales (consumption) of Salagen in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Pfizer - Decartis AG - AstraZeneca PLC - Akorn, Inc. - Genexine - ......
  • Europe Rituxan Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 109
    Notes: Sales, means the sales volume of Rituxan Revenue, means the sales value of Rituxan This report studies sales (consumption) of Rituxan in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Novartis AG - Fujifilm Kyowa Kirin Biologics - AstraZeneca PLC - Marsala Biotech......
  • Europe Prednisolone Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 105
    Notes: Sales, means the sales volume of Prednisolone Revenue, means the sales value of Prednisolone This report studies sales (consumption) of Prednisolone in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Pfizer - Merck - Allergan - The Medicines Company - Therava......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs